Norbrook Laboratories has announced the launch of Cefimam LC intramammary ointment for the management of mastitis.
Norbrook's large animal vet adviser Stephanie Small MRCVS said: "With such a broad range of treatments to choose from, vets are able to choose the product which best fits the situation. Cefimam® LC brings a powerful antimicrobial to the mix with high penetration for more difficult mastitis cases. Only three applications are required, which means fast resolution and rapid return of affected animals to production.
"This company firmly supports the large animal sector: as well as our commitment to making effective treatments affordable, we are investing in the future of the industry. We have worked closely with leading dairy vets to produce best practice materials for farming clients, and there are more educational tools in development."
Amongst these is a new guide called The Best Practice Guide for On-Farm Mastitis Control which you can now get from your Norbrook Territory Manager.
Cefimam LC is now available at all veterinary wholesalers in packs of 24 x 8g intramammary tubes.
For further information on Cefimam® LC, contact Senior Product Manager Chris Geddes MRCVS on 01536 741147
The CPD event takes place this Thursday 9th April, from 9:30am to 5:30pm, using the Zoom video conferencing platform. The organisers say that the agenda is still being finalised, but will be split into three streams: Farm Animal, Equine and Small Animal.
Confirmed speakers include:
Although the event is free, participants are asked make a voluntary contribution at justgiving.com/fundrasing/vets-for-nhs.
To register for the event, visit www.vetsfornhs.co.uk
Vets for NHS is supported by Boehringer Ingelheim, MSD Animal Health, Nimrod and the Scottish Vet Fair.
Vetoquinol is advising vets and farmers to be on the lookout following the discovery of counterfeit Marbocyl on two farms in Northern Ireland.
The counterfeit product contains an unapproved source of Marbofloxacin in an untested formulation which presents an unknown risk to animal and human health if used.
Vetoquinol has informed the national authorities about this situation. It is illegal either to sell or supply the product or to knowingly buy and/or use it.
The withdrawal period of this counterfeit product is unknown. Should the product be used it could be detected in milk or after slaughter. Vetoquinol advises the veterinary community to be aware of the risk, to carefully check the product packaging before use and to continue to source the product from reputable suppliers.
Vetoquinol urges vets and farmers to take the following actions if you find this product on farm or are approached to purchase it:
Vetoquinol says vets can rest assured that it will do all that is necessary to remove this product from the market.
If you need further information or advice, do not hesitate to contact Vetoquinol on 0800 1698197.
As Ceva points out, the change gives veterinary surgeons an opportunity to get more involved in parasite control plans and help farmers develop a sustainable parasite control strategy on their farm.
Eprecis injectable contains eprinomectin, the only molecule with zero-milk withdrawal currently available for cattle on the U.K. market.
Ceva highlights that because Eprecis is an injection, there is no risk of product transfer between in-contact animals caused by licking1,2,3 a natural behaviour of cattle, potentially resulting in sub-therapeutic levels of product being absorbed. There is also no risk of reduction in efficacy if dirt or manure is present on the back of the animal4.
The company says injectable formulation results in less active ingredient per animal treated compared to eprinomectin pour-ons; for example using Eprecis injection, a 500kg animal receives 100mg eprinomectin, while a pour-on delivers 250mg per application.
To support the new POM-V classification, Ceva has launched a vet support pack to help veterinary professionals when talking to their farming clients about Eprecis, worming strategies and their parasite control plans. The pack contains a farmer targeted brochure, farmer Q&A and a practical guide with suggestions of when Eprecis can be used. It also includes an infograph for social media posts, a technical booklet and a vet Q&A to help answer the most common questions they may be asked. A series of social media posts are available for vet practices encouraging their clients to discuss worming with their vet.
Kythé Mackenzie BVSc MRCVS, ruminant veterinary adviser at Ceva Animal Health, said: “Ruminants can be parasitised by a range of nematodes, trematodes and external parasites, all of which can have an impact on health and production. A recent publication considered that helminth infections (GIN, lungworm and liver fluke) cost the UK dairy industry close to £145M per year5. Interestingly, the majority of these costs were attributed to lost production (£131M) rather than treatment costs (£14M).
“There is now documented resistance to eprinomectin in small ruminants6 (Haemonchus contortus in goats) and whilst not yet documented in cattle, action needs to be taken to try and delay/minimise this emergence. This requires the use of more sustainable parasite control plans to assist in managing refugia and allowing animals adequate exposure to the parasites to develop natural immunity. Parasite control plans should maximise health, welfare and production whilst minimising the unnecessary use of anthelmintics.”
In the short-term, orders of Eprecis injectable from veterinary wholesalers will be fulfilled by the current POM-VPS product that is in the supply chain before switching to the new packaging later in the season.
For further information contact your local Ceva Animal Health territory manager or email cevauk@ceva.com.
References
The company has published data from its 2021 Assure Ewe subsidised testing scheme, which found that 48% of farms that submitted samples after last year’s lambing season tested positive for EAE1 caused by Chlamydia abortus.
This, Ceva says, mirrors the results from the 2020 testing initiative, demonstrating that EAE remains a significant issue on UK farms.
Katherine Timms BVetMed (Hons) MRCVS, ruminant veterinary advisor at Ceva Animal Health said: “EAE is a significant problem on UK farms, and it can be exceptionally expensive and frustrating to deal with, as infected sheep aborting and shedding have the potential to cause an abortion storm the following year.
“Any abortion outbreak should therefore be identified and managed as quickly and effectively as possible to help prevent the rest of the ewes in the flock from becoming infected.
"Vaccination and strict biosecurity provide the best protection against EAE and farmers can vaccinate their ewes from five months of age until four weeks prior to tupping, as long as the ewe is not in lamb.”
For further information, contact your local Ceva Animal Health account manager or visit www.enzooticabortion.co.uk.
Reference
Vetoquinol UK Ltd is launching a dedicated large animal/equine sales force on the 1st July.
The company says the move reflects the change in cattle and equine veterinary practice to become specialists.
Vetoquinol's large animal brands include: Marbocyl®, Sedalin®, Equistro®, Tolfine®, Pro Rumen and Locatim®.
The new team comprises:
The new sales team will be managed jointly by Hugh Gibson and Stuart Wade.
For further information or to make an appointment please contact your local Territory Manager direct or telephone 01280 825424
The voluntary scheme, which has been welcomed by Farming Minister George Eustice and Welsh Government Cabinet Secretary for Environment and Rural Affairs Lesley Griffiths, improves a herd’s ‘score’ every year it is free from a bTB breakdown, awarding a status of 0-10.
This new bTB scheme will require the herd vet and cattle owner to work together on following a number of biosecurity measures already successfully implemented in five other cattle disease control programmes.
As well as reducing risk of infection, the country-wide programme could present informed purchasing opportunities. In particular, it could benefit farmers selling cattle from regions with a high risk of the disease or who wish to minimise exposure from bought-in animals. It could also give recognition for a farmer’s efforts to complement Government and industry strategies to control infection.
Farming Minister George Eustice (pictured left above, with BCVA President Andrew Cobner) said: "Dealing with Bovine TB is costing us £100 million a year and causing devastation and distress for farmers and rural communities across the country. 33,000 cattle were slaughtered because of the disease last year alone and many farms are subject to movement restrictions which can affect their trade.
"But we know some 40% of herds in the high-risk area in England have never had a breakdown, and the CHeCS scheme will help them to communicate this so they can carry out risk-based trading to support their businesses.
"The scheme will also recognise those practicing good biosecurity, which is a core part of our long-term plan to tackle bovine TB."
The scheme complements the Government’s 25-year plan to eradicate Bovine TB in England, and will provide another tool for farmers who want to show they are following best practice. It follows the launch of the TB Hub (www.tbhub.co.uk), which offers practical advice and guidance as well as background into the disease.
The Cabinet Secretary, Mrs Griffiths, said: "The Welsh Government has been supportive of this initiative from the start. By focusing on individual herds, the scheme complements our proposed regional approach, for example those herds in the high TB areas which have not recently had TB will be able to demonstrate they are a lower risk.
"This industry-led initiative aimed at reducing TB is to be welcomed and fits in with our principles of working in partnership and promoting the benefits of disease prevention. I urge Welsh farmers to engage with the scheme and reduce the risk of disease being introduced into their herd."
Across Great Britain, CHeCS has over 14,000 member herds, representing around 14% of cattle holdings in some form of monitoring, control and eradication of disease.
Keith Cutler, CHeCS board member and partner in the Endell Veterinary Group, said: "CHeCS so far has focused on control of non-statutory diseases – Johne’s Disease, IBR, BVD, Leptospirosis and Neospora. Participating health schemes have been monitoring the health status of participating herds for some years.
"With this programme, we will be working with Government to receive official TB test data with the agreement of the farmer. It’s an exciting development for CHeCS, but there is a natural fit because of the expertise CHeCS-accredited health schemes already have with monitoring biosecurity measures on their members’ farms."
Andrew Cobner, president of the British Cattle Veterinary Association, who has been technical lead on the project since the start, said: "All too often we are confronted with the view that there is little or nothing that we can do to control TB. We wouldn’t accept this attitude with any other infectious disease so it’s time farmers and vets fought back. We have a government that is willing to embrace all of the measures necessary and we have a 25 year plan in place. Part of this will involve increasing biosecurity and risk-based trading, and CHeCS is leading the way."
The CHeCS bTb Herd Accreditation scores run from 0 (following all CHeCS measures but had a herd breakdown within the past 12 months), to 1 (following CHeCS measures and one year since the last herd breakdown) all the way though to 10 (following CHeCS measures and 10 years or more since the last herd breakdown).
Veterinary surgeons who think their clients might want to know more can point them in the direction of: www.checs.co.uk to read the technical standard, programme handbook and Q&A. If it sounds advantageous to their farm, they should discuss joining with you, then contact one of the participating CHeCS-accredited health schemes listed on the website. The application form includes a privacy agreement to allow the Animal and Plant Health Agency (APHA) to send test data automatically to the health scheme, and a declaration from the herd vet. After the form is sent back, a starting score will be awarded.
More information on bTB is also available at www.tbhub.co.uk.
A short survey, which has been emailed to BVA members this week, asks respondents to confirm which Official Controls Qualifications (OCQ(V)s) they currently hold or previously held.
They are also asked to give reasons if they have chosen to drop a particular qualification without revalidating it.
The BVA says members have raised concerns via Council about the OV training and revalidation process, citing time, cost, a lack of relevance and duplication of learning across different modules as reasons for choosing not to renew their qualifications.
The BVA plans to take the data and insights captured in the survey to the Animal and Plant Health Agency (APHA) and make recommendations for how the system can be made more user-friendly and fit for purpose.
John Fishwick, BVA President, said: "Official Veterinarians have a critical role to play in upholding high standards of health and welfare across the supply chain, certifying products for export and safeguarding against disease and food fraud. We are already aware that this area is facing significant challenges as Brexit is likely to drive up demand for product certification.
"It is particularly worrying to hear that members are finding the system both frustrating and resource-intensive. Losing skilled professionals now at a time when they are needed most would be a real waste of specialist knowledge and could leave gaps in the UK’s provision for responding to disease outbreaks and meeting export certification needs post-Brexit.
"We understand and support the need to keep veterinary skills up to date, but the process for demonstrating this must be straightforward and proportionate. BVA will ensure that all insights offered by respondents are raised with APHA with the aim of getting the system right for OVs working in the UK both now and in the future."
BVA members can access the survey at https://www.surveymonkey.co.uk/r/7Y2Y3RR. The deadline for responding is 29 June 2018.
The small animal and business meeting takes place on the 2nd and 3rd October. The farm and business national meeting is on the 18th and 19th September, and the equine and business meeting is on the 9th and 10th October.
The small animal meeting will also cover other topics such as the art of conversations to dentistry, while the farm meeting will focus on team working, competitive advantage, genomics and mental resilience.
All three events include a team-based activity and a social evening which offers the chance to network and exchange experiences and ideas.
Susan Goodfellow, the Chief Marketing Officer at XLVets said: "It's fine to know what we do but to actually experience it as part of our community is quite different. We know that talking to members and being part of a group of individuals that come together to determine their own future is the best way for veterinary professionals to see what's possible and how we strive for excellence together."
XLVets is also encouraging anyone who is thinking about starting their own practice to attend the events; the company has a number of programmes designed to support prospective owners with things like finding funding, identifying the right financial set up, and acquiring the skills needed to lead a team effectively.
Susan says many vets have a strong entrepreneurial mindset but lack support or know-how to allow them to take the first step to ownership: "Locum roles and mobile set ups are often stepping stones to practice ownership but the barriers can seem significant, not to mention any personal reservations people might have about all it entails. Support from like-minded colleagues who can openly share their experiences can help to make it seem possible, desirable and achievable."
Veterinary professionals wishing to attend one of the meetings should contact Colm McGinn, Chief of Implementation, in confidence, at colm.mcginn@xlvets.co.uk or call 01228 711788.
Colivet® solution, one of CEVA Animal Health’s range of 3 soluble antimicrobials for pigs has been renamed Coliscour®.
Phil McGuire, CEVA’s business unit manager, explains the reasoning behind the name change: “We simply felt that the easiest way to avoid confusion between our product and a totally different non-prescription product of a similar name was to give ours a new name that also reflects its use, hence Coliscour®.”
The BVA has challenged the Food Standards Agency (FSA) to take further investigative action to enable Defra to consider prosecutions against the Essex abattoir where appalling animal welfare abuses were highlighted in footage obtained by Animal Aid.
The footage shows pigs being abused and manhandled in breach of animal welfare legislation.
BVA President Harvey Locke said: "There must be confidence in the systems that regulate and license slaughter and the people responsible for carrying it out. I have written to the Chief Executive of the FSA outlining our concerns at the lack of any action towards prosecution.
"The method by which the issue was highlighted should not, in our opinion, preclude further investigation by the FSA and Defra into these incidents with a view to lawfully obtaining evidence to either support or refute the accusations arising from the Animal Aid footage."
Mr Locke added: "The UK food industry prides itself on high welfare standards. Animal cruelty is not acceptable and action must be taken. These are serious welfare issues and investigations into this sort of blatant abuse and appalling treatment of animals must be pursued vigorously."
In his letter to the FSA Mr Locke reiterated the BVA's views on the specific issue of CCTV in abattoirs at the stunning/slaughter point, stressing that Food Business Operators (FBOs) must have effective procedures in place either to constantly monitor stunning and slaughter operations, or to enable the FBO or their Animal Welfare Officer to inconspicuously observe stunning and slaughter operations at any time: such arrangements may include an aperture or window into the stunning area or the use of CCTV by the FBO for welfare monitoring and management purposes.
Join the discussion here.
CEVA Animal Health has launched the anti-inflammatory Meloxidyl for cattle and pigs.
Meloxidyl is meloxicam-based solution for the management of respiratory disease, mastitis and diarrhoea in cattle and non-infectious locomotor disorders and puerperal septicaemia and toxaemia in pigs. It is given via a single injection, when used in combination with suitable anti-infectives.
According to the company, Meloxidyl's one shot protocol means it is quick and economical to use; it allows control of inflammation and endotoxins and reduces somatic cell count, recovery time and risk of culling after clinical mastitis; it reduces the economical impact of respiratory signs in comparison with flunixin-based products and reduces the major clinical signs caused by toxins in cases of neonatal diarrhoea.
Meloxidyl can be used in combination with the company's range of anti-infectives, which includes Marbokem, Cevaxel and Florkem.
For further product information contact CEVA Animal Health Ltd, 90 The Broadway, Chesham, Bucks, HP5 1EG, telephone 01494 781510 or visit the website at http://www.ceva.uk.com/
Agrimin has announced the launch of a new range of boluses for sheep and cattle that use 'eroding technology' to deliver a sustained supply of three trace elements for up to 180 days:
According to Agrimin, each bolus is designed to provide the full daily requirement of cobalt and selenium and the largest available daily supply of iodine to both cattle and sheep. The boluses do not contain any copper, an element known to cause issues in certain parts of the country, in closely managed dairy cows or in continental sheep breeds.
Each bolus is made up of two parts, held together by a soluble wrapper. After administration, the wrapper dissolves and the two halves remain in the reticulum where they erode and dissolve. This process delivers a continuous and regular supply of nutrients to the animal.
Agrimin's Dr Jamie Bennison said that the new range has been extensively trialled in New Zealand and at Glasgow Veterinary School: "Trials have confirmed a sustained release profile which ensures that iodine, selenium and cobalt levels are maintained throughout the active life of the bolus. In farm trials this has translated into higher levels of the elements in blood samples and improved animal productivity."
Treatment is one bolus per animal (48g for sheep; 160g for cattle) administered with an Agrimin bolus gun. One bolus is sufficient to meet the animal's full daily requirement for 180 days.
For more information about the 24•7 Iodine•Selenium•Cobalt range of cattle and sheep boluses, please visit http://www.agrimin.com/ or call 01652 688046.
The researchers say the effectiveness of cheaper devices could result in wider use amongst farmers, vets and hoof trimmers helping to identify lameness earlier.
The study, led by RVC undergraduate veterinary student, Aidan Coe, alongside Dr Nicola Blackie, a senior lecturer in Production Animal Science at the RVC, compared the thermal images of 83 cows’ hind feet, captured with both high and low cost thermal imaging devices.
Very little difference was identified in the performance and quality of the devices despite the low-cost device being 2% the cost of the high cost device.
Images captured suggested that low-cost thermal imaging devices would be the most cost-effective choice to aid in the identification of lameness.
This study highlights the effectiveness of cheaper infrared thermal imaging devices in identifying the condition which has the potential to lead to the wider use of the devices by farmers, vets and hoof trimmers, in turn allowing the condition to be identified earlier.
Whilst high-cost devices have sometimes been used to detect lameness in cattle, the price point of up to £20,000 and fragility has previously limited their usefulness in a farm setting.
Aidan Coe, Undergraduate Veterinary Student at the RVC, and lead researcher on this paper, said: “There is a possibility that low-cost infrared thermal imaging devices could be used as an objective, cost-effective method of assessing the lameness of the national herd, which may prove a useful adjunct to the current lameness detection methods.”
The full paper can be accessed at: https://www.mdpi.com/2306-7381/9/8/414
The tracker, which Elanco produces with NADIS (National Animal Disease Information Service), highlights areas hit with blowfly strike in real-time, to provide a warning for farmers, veterinary surgeons and industry professionals.
The first reported incidents were in Hampshire, before spreading across Devon, West Sussex, and Buckinghamshire. Elanco says particularly severe cases include a flock in Dorset, in which 50% of a lamb group have been hit by blowfly strike. Latest reports are in northern England and some initial cases in Scotland.
The company says its blowfly risk forecast suggests that weather conditions from southern England and Wales to the Midlands mean that flies are now active, and females are laying eggs that could result in serious welfare and productivity issues.
Richard Wall, Professor of Zoology at Bristol University, said: "The timing and severity of blowfly strike is strongly influenced by the weather. This is a reminder to farmers that now is the time to act for early prevention. Delaying treatment not only costs the farm but risks the welfare and productivity of the flock."
Fiona Hutchings, Technical Vet at Elanco, said: "The costs of inaction when it comes to blowfly strike far outweigh the costs of protection. With 99% of farmers having suffered financial losses as a result of blowfly strike¹, the potential impact on your flock simply isn’t worth the risk. Farms need to take control — and take control early — by using a preventative IGR product with full fleece protection2."
Fiona added: "By the time symptoms show themselves, it’s often too late. It’s easy to overlook even one struck sheep, and blowfly strike can cause huge damage in very little time. In addition, using protection early reduces risk later in the season by ensuring a much lower fly count as the season progresses."
Fort Dodge Animal Health has announced that its Zulvac 8 Ovis® Bluetongue sheep vaccine is now licensed and available in the UK. The company believes that the product will provide significant benefits to sheep farmers.
Zulvac 8 Ovis® is an inactivated adjuvanted vaccine for the active immunisation of sheep by subcutaneous injection against Bluetongue Serotype 8. It also provides a reduction in viraemia. Administration is a two x 2 ml dose primary course in year one but only a single shot booster in the second year.
The use of Zulvac 8 Ovis as a booster for animals previously vaccinated with a primary course from other manufacturers is in line with Defra (2009) guidance: 'No problems are anticipated with re-vaccinating animals which have already received a primary course of vaccination with a different vaccine 1'.
The first dose can be administered from one month of age and Zulvac 8 Ovis® is proven for use in pregnant sheep. The onset of immunity is provided 25 days after the second dose.
Fort Dodge says Zulvac provides cost savings to farmers through its pricing strategy. While the price for the two dose primary course is competitive with alternative vaccines, for animals which were vaccinated last year and require only a single shot booster, the cost will be half that of competitive offerings, providing a significant incentive to farmers to vaccinate.
The vaccine is supported by a specific Zulvac Ovis fixed 2ml dose applicator with Sterimatic needle protector and cleaning system which aids administration and hygiene and is sold separately.
David Bartram MRCVS, Veterinary Technical Manager at Fort Dodge, said: "Sheep farmers have been waiting for a Bluetongue vaccine which offers a cost effective solution to vaccination - particularly for animals which received their primary course last year and are simply in need of a booster. We expect the fact that it's licensed for use in pregnant sheep to also prove attractive.
"Zulvac 8 Ovis® is the latest addition to Fort Dodge's Zulvac range for both cows and sheep. It is already used in Europe and has helped protect millions of animals."
Ceva says CLAS vials are proven to be easy to use, practical and eco-friendly and are preferred by 99% of farmers on farm1. They have 33% less impact on the environment from cradle to grave than glass2 and are robust and shock resistant3 for fewer breakages and losses. They are made from a lightweight material to make the vials easier to be transported and handled4 and have an ergonomic ‘grip groove’ for easier handing5.
Peter Keyte, ruminant business unit manager at Ceva Animal Health said: "Ceva’s CLAS vials are hugely popular with both vets and farmers due to their practicality, ease of use and environmental credentials.
“We are therefore delighted that Ketofen has joined the extensive range of livestock injectables available in CLAS.”
For further information contact your local Ceva territory manager, call Ceva on 01494 781510 or email cevauk@ceva.com.
New legislation will be introduced in the New Year making slaughterhouse CCTV a legal requirement in all areas where live animals are present, with unrestricted access to at least 90 days of footage for Official Veterinarians. The new law will come into force in the spring, with slaughterhouses allowed an adjustment period of up to six months.
The new legislation followed a public consultation which was overwhelmingly in favour of compulsory CCTV. Defra says that out of almost 4,000 respondents, more than 99% were supportive of the plans.
Environment Secretary Michael Gove said: "We have some of the highest animal welfare standards in the world and want to cement our status as a global leader by continuing to raise the bar.
"The reaction to this consultation highlights the strength of feeling among the public that all animals should be treated with the utmost respect at all stages of life and be subject to the highest possible welfare standards.
"These strong measures also provide a further demonstration to consumers around the world that as we leave the EU we continue to produce our food to the very highest standards."
BVA Senior Vice President Gudrun Ravetz said: "The mandatory installation of CCTV is a vital tool to ensure high standards of animal health, welfare and food safety in all slaughterhouses.
Official Veterinarians carry out an essential role in slaughterhouses by independently assessing and reporting breaches of animal welfare, and unrestricted access to CCTV footage will allow them to carry out this role even more effectively.
We have been campaigning for these measures for a number of years and it is reassuring to see such a high level of support for their implementation from industry and the public."
Heather Hancock, Chairman of the Food Standards Agency, said: "The Secretary of State’s decision to require CCTV in all slaughterhouses is a welcome step towards ensuring that animal welfare and hygiene standards are met across the meat industry.
"Last year, the FSA Board concluded that, without mandatory CCTV in slaughterhouses, we would see minimal further progress in businesses improving animal welfare or complying with official controls to protect public health.
"We look forward to working with the industry as CCTV plans are implemented, and to seeing public confidence rise as a result."
The government will now further discuss the details of bringing in the proposals and present draft legislation to Parliament as soon as Parliamentary time allows.
Photo: Lititz, Pennsylvania. Hoisting a slaughtered steer in Benjamin Lutz's slaughterhouse, 1942. Wikipedia.
During the 60 days before to 30 days after calving, dairy cows experience a dip in their natural immunity, leaving them especially vulnerable to important diseases such as mastitis2, metritis3 and retained placenta.4 With serious cost consequences and implications for cow welfare and productivity, this makes the transition period one of the most challenging yet vital periods for vets to manage with dairy clients.
Imrestor (pegbovigrastim injection) is a pegylated form of the naturally occurring protein cytokine, bovine Granulocyte Colony Stimulating Factor (bG-CSF). Elanco says it helps restore the cow’s natural defences by increasing the number and restoring the function of neutrophils, the primary type of white blood cell that recognizes and kills harmful bacteria.
Fiona Anderson, Technical Vet at Elanco, said: "It’s no secret that a successful transition period is vital for maximising productivity in the next lactation, yet we are still ‘firefighting’ common transition diseases like mastitis rather than focusing on their true cause."
"Vets are under increasing pressure to adopt a more proactive approach, not least to reduce the use of antibiotics in livestock but with few credible alternatives. This can be challenging in dairy herds, particularly around calving when cows are susceptible to multiple disease challenges while their defences are low. Imrestor helps to restore a cow’s own natural immunity and strengthen her ability to defend against infection by a range of mastitis pathogens – thus helping to protect the cow against mastitis when she needs it most."
Available in pre-filled, single-dose syringes, Imrestor is administered with two injections – one seven days prior to the anticipated date of calving and the other within 24 hours after calving – with neither injection requiring a withdrawal period.
Kingsley Baxendale, Ruminant Marketing Manager at Elanco Animal Health said: "It can be extremely frustrating for vets to see their dairy farmers struggling with the stress and hassle of dealing with increased numbers of sick cows during calving; they have enough to deal with at the moment. We’re delighted that Imrestor can provide vets with a tool to help decrease the negative consequences associated with immune-related diseases like mastitis and maximise their herds’ lactation potential."
As part of the launch of Imrestor, Elanco also announced its new 'Pledge To Protect' initiative to encourage vets and farmers to make a pledge symbolising their commitment to address immune suppression in their dairy cows.
The number of pledges will be tracked using a life-sized 2D cow model, pictured above. For each pledge, which can be made online or at events, Elanco will make a £5 donation to The Royal Agricultural Benevolent Institution (R.A.B.I), which supports farmers in difficulty. As a thank you for showing support, all pledgers will automatically be entered into a weekly prize draw.
To find out more about using Imrestor and how you can make your pledge, visit www.vital90days.co.uk.
The webinar, titled: ‘When the coughing won’t stop…. what to do when standard BRD treatment protocols aren’t getting to the bottom of it’, aims help vets manage complex outbreaks that happen despite best practice management and treatment protocols.
The full programme includes:
The event is being held live so you can submit questions to the speakers, but the session will be recorded, so it can be watched again later.
Attendees will receive a certificate for one hour of CPD and the link to the recorded webinar.
To register, email the event team by 27 November 2020 at brdwebinar-group@ceva.com. In the email, please give your name and the email address to which you would like the registration link sent.
The Boehringer Academy (www.boehringer-academy.co.uk) contains hundreds of hours of CPD material on equine, companion and production animals. It comprises a mixture of webinars, podcasts, short videos and downloadable documents, which can be viewed at any time. The site keeps a CPD log for each user and provides downloadable certificates.
Boehringer’s Small Animal Marketing Team Leader, Jemima Mead said: "We already have just over 15,000 vets and nurses in the UK and Ireland currently registered with the Academy.
"New and existing members are eligible to receive the Boehringer Academy colouring book. They simply have to visit www.boehringer-academy.co.uk and complete their profile. In addition, everyone completing their profile will be entered into a draw to win an iPad Pro and Apple Pencil."
The recategorisation means that pharmacists and Suitably Qualified Persons (SQPs) will be able to prescribe Zolvix.
The VMD says that making the anthelmintic more widely available will increase its usage as part of strategic worm control programmes on farms, which could in turn result in long term health benefits for sheep, for example by reducing the development and spread of anthelmintic resistance, thereby prolonging the effective use of anthelmintics.
The VMD adds that SQPs will now have additional training to ensure they are sufficiently familiar with Zolvix and how to prescribe it effectively and responsibly so that it is used appropriately. A new compulsory training module will be implemented by The Animal Medicines Training Regulatory Authority (AMTRA) to augment the skills of all AMTRA-registered SQPs permitted to prescribe farm animal products. New SQPs will be required to undertake a revised and extended module before gaining their farm animal registration with AMTRA.
Pharmacists and SQPs will be able to prescribe Zolvix from 1st July 2017.
UPDATE 16th March:
BVA President Gudrun Ravetz has issued a statement expressing concern over the recategorisation of Zolvix:
"We know that resistance to anthelmintics is increasing in grazing animals and needs to be addressed if the livestock industry is to avoid a potentially disastrous situation of being unable to tackle parasites. The reclassification of Zolvix from POM-V to POM-VPS is in direct opposition to the trend in Europe, where we are seeing increased control over dispensing of anthelmintics in species where resistance is a serious threat to animal welfare and profitable production; we're extremely concerned that we might start seeing resistance develop in group 4 as a result.
"BVA believes that prescribing of anthelmintics requires a level of control best provided by a veterinary surgeon who has the animals under his/her care, and is based on a sound clinical diagnosis, in order to protect animal welfare and safeguard the efficacy of these products for the future."
Further information on BVA's policy on anthelmintics can be found on BVA’s website: www.bva.co.uk/news-campaigns-and-policy/policy/medicines/anthelmintics.
This third biennial offering from GB’s Cattle Health and Welfare Group also contains a summary of progress on endemic disease control with advances in eradicating Bovine Viral Diarrhoea (BVD) in each country highlighted.
The Chief Veterinary Officers of UK, Scotland and Wales have welcomed the publication of the report saying that as the possible impacts of the referendum on leaving the EU are considered, the importance of a GB focus on disease control is as important as ever.
In their joint forward, Nigel Gibbens, Sheila Voas and Christianne Glossop said: "The healthier our animals, the more attractive our products. The better our animal welfare, the greater the confidence of consumers in our production systems.
"With the UK Government placing AMR at the top of its risk register alongside terrorism and pandemic ’flu, it is heartening to see that CHAWG, in common with other livestock sectors, has grasped the nettle in looking first at how the cattle sector can better capture data on use of antimicrobials."
They go on to say that addressing AMR helps address other imperatives as an emphasis on sound animal husbandry and healthy animals kept to high welfare standards will help minimise routine reliance on antimicrobials: "Success in controlling endemic disease is one area of considerable importance, and here we can highlight CHAWG’s pivotal role in the development and promotion of national disease control programmes. These include the launch of the BVDFree scheme in England earlier this year, ongoing progress with BVD eradication in Scotland, the development of a Wales BVD scheme, and the Action Johne’s initiative."
In the report’s conclusion, RSPCA’s head of farm animals Marc Cooper points out that it is clear many positive initiatives are being pursued within the industry. He said: "Notable amongst these are those associated with dairy cow genetics, eliminating BVD, the national dairy cow welfare strategy and the development of a data hub for the collation of information relating to antimicrobial use.
"Indeed, some of these are starting to realise improvements in key areas, for example, dairy cow longevity is beginning to increase, and cow fertility figures and somatic cell counts appear to be moving in the right direction.
"However, there are still ongoing concerns relating to some important health and welfare issues. For example, despite the evidence suggesting the annual prevalence levels of cattle lameness are beginning to fall, there still appears to be no centralised database for recording it."
Chairman of CHAWG Tim Brigstocke says the contributed comments are encouraging and provide positive direction for future CHAWG activities. He also reassures that while this report sees a number of advances in highly topical areas, ‘core’ activities are not being ignored. He said: "Effective farm health planning remains the bedrock of good practice. And while we tend to focus on areas which need improvement, it’s worth mentioning that a delegation from the Food & Veterinary Office (FVO) of the European Commission recently visited and were impressed by the coordinated approach taken in this country."
The report can be downloaded from www.chawg.org.uk.
CEVA Animal Health has launched a double-sized version of Cyclo Spray, the company's chlorotetracycline-based treatment for the clinical symptoms of foot rot in sheep and digital dermatitis in cattle.
CEVA says that Cyclo Spray's superior spray performance makes it very cost-effective: the aerosol generates a narrow, condensed spray with limited dispersion for accurate application and minimal drip. The spray adheres cleanly and dries fast on the treatment area, to ensure that the antimicrobial has maximum efficacy within the shortest possible spray time.
CEVA adds that each spray of Cyclo Spray covers the skin with a concentration of chlorotetracycline that is thousands of times greater than is actually required to kill the causative bacteria.
The original size can is also available if required.
For further information contact CEVA Animal Health Ltd, 90 The Broadway, Chesham, Bucks, HP5 1EG.
The RCVS has announced that registrations for the new RCVS Register of Veterinary Practice Premises will be accepted from 1 November 2008, allowing all those who wish to supply medicines from veterinary practice premises from 1 April 2009 onwards a full five months to comply with the latest medicines legislation.
In order to fulfil its obligations under European law to maintain and improve traceability of, and accountability for, veterinary medicines, the UK Government decided that any veterinary surgeon may only supply veterinary medicinal products (VMPs) from premises registered with the Secretary of State, with effect from 1 April 2009.
The Veterinary Medicines Directorate (VMD) is responsible for the inspection and registration of practices under the Veterinary Medicines Regulations. Steve Dean, VMD's Chief Executive, says the new veterinary practice premises register will complete the UK information base by bringing veterinary practices in line with other suppliers of veterinary medicines who already have to operate from registered premises.
The Register will enable the supply of veterinary medicines by veterinary surgeons, including controlled drugs, to be subjected to inspection and verification. As a result, DEFRA Ministers and the European Commission can be re-assured that veterinary medicines are being supplied in the UK in accordance with EC legislation.
In discussion with the VMD, it was agreed that the most appropriate body to maintain this register would be the RCVS, not least because the College already manages the RCVS Practice Standards Scheme and publishes the (voluntary) Directory of Veterinary Practices, so has the necessary systems already in place. The register will be published on RCVSonline and updated quarterly.
Whilst there will now be a statutory fee levied for each practice premises registered on the new Register, the College's existing database framework has kept this to a relatively low £40 compared to what other bodies might have had to charge after starting from scratch.
Practices could appear in the Directory for free because the cost of producing it was partially covered by subsequent data sales. However, the new Register will need to be self-funding, as the data it contains will be freely available online.
Not all practices will have to pay the statutory fee. RCVS President Jill Nute said: "For those practice premises already accredited under the RCVS Practice Standards Scheme (PSS), the fee will be taken from their existing PSS annual fee.
"What's more, accredited practices will not face additional four-yearly inspections by VMD inspectors (unless there is an investigation for enforcement purposes) as their PSS inspections already ensure that they keep up to date with current medicines legislation."
Practice premises that have applied to join the Scheme, but have not yet been accredited, will not face additional VMD inspections either, but will still need to pay the statutory fee.
To help practices understand the new requirements and what they need to do before next April, the RCVS has produced a range of guidance, including a series of Frequently Asked Questions (www.rcvs.org.uk).
"In particular, we hope this guidance will help to explain which premises are likely to be considered ‘veterinary practice premises' and the difference between those premises and places where medicines might simply be stored or kept," said Mrs Nute.
"It is important to realise that there is a legal requirement to register veterinary practice premises for the supply of medicines, and a professional obligation, set out in the Guide to Professional Conduct, to keep a record of where all medicines are stored or kept. This record should avoid the need for additional registration of car boots, farms and homes."
Over the coming weeks, application forms will be posted to all practices currently listed in the Directory and accredited under the PSS, containing all the practice information currently held. These forms must be checked, signed and returned, even if no fee is due. Separate application forms will be available for any non-accredited practice premises not published in the Directory, and a letter will be sent to all RCVS members to ensure the whole profession is aware of the new requirements.